Investment Japan
Ever since Japan’s Financial Services Agency (FSA) released “Progress Report on Enhancing the Asset Management Business 2020” last June, a hot topic in the country has been the use of subadvisors to enhance asset management capability. Many of the world’s leading assets managers have served as subadvisors in Japan’s
toshin market, but it is only with the recent success of foreign equity funds that their role has drawn significant attention. (
T
toshi-shintaku, or investment trust akin to mutual funds and closed-end funds in the U.S.)
Shoko Shinoda, Fund Analyst of Rakuten Securities Inc. says, “There has been an excessive focus on cost in the last few years, and subadvisors have been regarded as a contributor to increased costs. With the recent strength of the stock market, however, investors have realized that performance outweighs cost. Funds that have performed well, such as Baillie Gifford and ARK, have attracted attention and, as a result, the
Japan
Mamoru-oizumi
Shoko-shinoda
Yasuo-sasai
Baillie-gifford
Pimco
Fund-analyst-of-rakuten-securities-inc
Goldman-sachs
Product-development-division
Japan-financial-services-agency
Fund-management-division
Jp-morgan
Sampath Bank recently announced the launch of Sri Lanka’s first Visa powered business debit card linked to a corporate account – the Sampath Bank Visa Business Debit Card – to help businesses of all sizes gain more control over their expenses.
The Bank’s business customers will now be able to move away from cash and provide separate Debit Cards to their employees for day-to-day expenditure. They can set monthly transaction limits to each individual card and link the cards to their preferred company account with Sampath Bank. The chosen account will be directly debited each time an employee makes a payment using the card. Businesses can consolidate all spending information using the detailed electronic reports it offers and simplify their payments, bookkeeping, reporting and monitoring processes.
Sri-lanka
Sri-lankan
Tharaka-ranwala
Central-bank
Visa
Sampath-bank-visa-business-debit-card
Sri-lanka-ports-authority-customs
Distribution-services
Sampath-bank
Sampath-bank-vishwa-corporate
Sampath-bank-cheque-printing
It-team
Yingli Pharma and Hengrui Medicine Reach a Strategic Agreement to Jointly Explore the Oncology Market in China
News provided by
Share this article
Share this article
SHANGHAI, Feb. 8, 2021 /PRNewswire/ Yingli Pharma announced today that it reached strategic collaboration with Hengrui Medicine (600276.SH), a partnership which will significantly accelerate the expansion of Yingli Pharma s oncology business in China, the second largest pharmaceutical market in the world. As an innovation-driven enterprise, Yingli Pharma demonstrates commitment to continuous investment in R&D and is committed to the research, development and commercialization of new drugs for hematological tumors, solid tumors and kidney-related metabolic diseases.
China
Shanghai
Zhangjiang
Zhejiang
Zhang-lianshan
Yingli-pharma
Prnewswire-yingli-pharma
Xu-zusheng
Hengrui-medicine
Senior-deputy-general-manager
Shanghai-yingli-pharma